Gastroenterology and Hepatology, University of Utah Health, Salt Lake City, UT.
Department of Medicine, Jersey Shore University Medical Center, Neptune City, NJ.
J Clin Gastroenterol. 2024 Oct 1;58(9):902-911. doi: 10.1097/MCG.0000000000001948.
We compared the safety and outcomes of percutaneous jejunostomy tubes placed endoscopically (PEJ), fluoroscopically by interventional radiology (IR-jejunostomy), and open jejunostomy placed surgically (surgical jejunostomy).
Using the Nationwide Readmissions Database, we identified hospitalized patients who underwent a jejunostomy from 2016 to 2019. Selected patients were divided into 3 cohorts: PEJ, IR-jejunostomy, and surgical jejunostomy. Adjusted odds ratios (OR) for adverse events were calculated using multivariable logistic regression analysis.
A total of 6022 (65.2±9.8 y) surgical jejunostomy patients, 3715 (63.6±11.0 y) endoscopic jejunostomy patients, and 14,912 (64.8±11.6 y) IR-jejunostomy patients were identified. Compared with surgery, PEJ patients were 32% less likely to experience postprocedure complications (OR: 0.68; 95% CI: 0.58-0.79, P <0.001) while IR-jejunostomy patients were 17% less likely to experience complications (OR: 0.83; 95% CI: 0.73-0.94, P <0.001); test of proportion showed that endoscopy had significantly fewer total adverse events compared with IR ( P <0.001). For individual complications, compared with surgery, the odds of intestinal perforation using PEJ and IR, respectively, were 0.26 (95% CI: 0.14-0.49, P <0.001) and 0.31 (95% CI: 0.21-0.47, P <0.001), for postprocedure infection 0.32 (95% CI: 0.20-0.50; P <0.001) and 0.61 (95% CI: 0.45-0.83; P =0.001); and for hemorrhage requiring blood transfusion 0.71 (95% CI: 0.56-0.91; P =0.005) and 0.75 (95% CI: 0.61-0.91; P =0.003).
Endoscopic placement of percutaneous jejunostomy tubes (PEJ) in inpatients is associated with significantly lower risks of adverse events and mortality compared with IR and surgical jejunostomy.
我们比较了经内镜(PEJ)、介入放射学(IR-jejunostomy)和外科手术(外科 jejunostomy)放置经皮空肠造口管的安全性和结果。
使用全国再入院数据库,我们确定了 2016 年至 2019 年期间进行空肠造口术的住院患者。选择的患者被分为 3 个队列:PEJ、IR-jejunostomy 和外科 jejunostomy。使用多变量逻辑回归分析计算不良事件的调整优势比(OR)。
共确定了 6022 例(65.2±9.8 岁)外科 jejunostomy 患者、3715 例(63.6±11.0 岁)内镜 jejunostomy 患者和 14912 例(64.8±11.6 岁)IR-jejunostomy 患者。与手术相比,PEJ 患者术后并发症的风险降低了 32%(OR:0.68;95%CI:0.58-0.79,P <0.001),而 IR-jejunostomy 患者并发症的风险降低了 17%(OR:0.83;95%CI:0.73-0.94,P <0.001);比例检验表明,内镜检查的总不良事件明显少于 IR(P <0.001)。对于个别并发症,与手术相比,使用 PEJ 和 IR 的肠穿孔的几率分别为 0.26(95%CI:0.14-0.49,P <0.001)和 0.31(95%CI:0.21-0.47,P <0.001),术后感染的几率分别为 0.32(95%CI:0.20-0.50;P <0.001)和 0.61(95%CI:0.45-0.83;P =0.001);需要输血的出血并发症的几率分别为 0.71(95%CI:0.56-0.91;P =0.005)和 0.75(95%CI:0.61-0.91;P =0.003)。
与 IR 和外科 jejunostomy 相比,住院患者经内镜放置经皮空肠造口管(PEJ)与不良事件和死亡率的风险显著降低相关。